Yitian Zhou

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

Integrating rare genetic variants into pharmacogenetic drug response predictions

Magnus Ingelman‐Sundberg, Souren Mkrtchian, Yitian Zhou et al. · Human Genomics · 2018 · 211 citations · Full text

Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions

Sabine U. Vorrink, Yitian Zhou, Magnus Ingelman‐Sundberg et al. · Toxicological Sciences · 2018 · 172 citations · Full text

Immunology, Pathology, Translational Medicine +19

An optimized prediction framework to assess the functional impact of pharmacogenetic variants

Yitian Zhou, Souren Mkrtchian, Masaki Kumondai et al. · The Pharmacogenomics Journal · 2018 · 145 citations · Full text

Tetrandrine alleviates silicosis by inhibiting canonical and non-canonical NLRP3 inflammasome activation in lung macrophages

Meiyue Song, Jiaxin Wang, Youliang Sun et al. · Acta Pharmacologica Sinica · 2021 · 98 citations · Full text

Asthma, Inflammatory Lung Disease, Lung Inflammation +16